2m 2m 2m 2m 2m 2m 2m
AMN Healthcare (AMN)
NYSE
$31.63+$0.39 (+1.25%)
Price as of Jun 23, 2026 7:43 PM EDT- $1.2BMarket Cap
- 43.25%1-Year Change
- Medical Care FacilitiesIndustry
AMN Healthcare (AMN)
$31.63+$0.39 (+1.25%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.7B -8.49% | 3.0B -21.26% | 3.8B -27.73% | 5.2B +31.60% | |
Cost of Revenue | 2.0B -5.23% | 2.1B -18.71% | 2.5B -27.98% | 3.5B +31.85% | |
Gross Profit | 774.1M -15.81% | 919.4M -26.43% | 1.2B -27.21% | 1.7B +31.08% | |
Sales and Marketing Expense | 593.0M -6.24% | 632.5M -16.36% | 756.2M -19.26% | 936.6M +28.22% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 156.6M -9.89% | 173.8M +7.99% | 160.9M +17.37% | 137.1M +32.22% | |
Total Operating Expenses | 829.5M -18.84% | 1.0B +12.17% | 911.2M -14.81% | 1.1B +28.62% | |
Operating Profit | -55.5M -45.97% | -102.7M -130.34% | 338.4M -47.70% | 647.1M +35.38% | |
Interest Income | 106,000 +153.00% | -200,000 -33.77% | -302,000 -59.68% | -749,000 N/A | |
Interest Expense | N/A N/A | N/A N/A | -54.1M +34.02% | -40.4M +18.55% | |
Interest Income and Expense and Net | 106,000 +153.00% | -200,000 -99.63% | -54.4M +32.31% | -41.1M +20.75% | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | 54.1M +34.02% | 40.4M +18.55% | |
Income before Taxes | -101.1M -41.44% | -172.6M -160.70% | 284.3M -53.14% | 606.7M +36.67% | |
Income Taxes | -5.4M -79.05% | -25.6M -134.77% | 73.6M -54.74% | 162.7M +39.58% | |
Extraordinary Items | N/A N/A | N/A N/A | 0 N/A | 0 N/A | |
Net Income | -95.7M -34.89% | -147.0M -169.76% | 210.7M -52.56% | 444.1M +35.63% | |
Net Income from Continuing Operations Applicable to Common | -95.7M -34.89% | -147.0M -169.76% | 210.7M -52.56% | 444.1M +35.63% | |
Basic EPS and Net Income | -2.48 -35.58% | -3.85 -171.56% | 5.38 -45.98% | 9.96 +44.98% | |
Diluted EPS and Net Income | -2.48 -35.58% | -3.85 -171.83% | 5.36 -45.86% | 9.90 +45.37% | |
Basic Weighted Average Shares | 38.5M +0.87% | 38.2M -2.51% | 39.2M -12.15% | 44.6M -6.49% | |
Diluted Weighted Average Shares | 38.5M +0.87% | 38.2M -2.93% | 39.3M -12.32% | 44.9M -6.61% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 34.0M +219.02% | 10.6M -67.67% | 32.9M -48.96% | 64.5M -64.34% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 34.0M +219.02% | 10.6M -67.67% | 32.9M -48.96% | 64.5M -64.34% | |
Total Current Assets | 545.4M -8.33% | 594.9M -29.32% | 841.7M -23.04% | 1.1B -18.93% | |
Accumulated Depreciation | 414.8M +14.97% | 360.8M +26.56% | 285.1M +25.25% | 227.6M +19.83% | |
Property and Plant and Equipment and Net | 136.4M -26.79% | 186.3M -2.67% | 191.4M +28.21% | 149.3M +17.43% | |
Total Long-Term Assets | 282.6M +9.49% | 258.1M +8.98% | 236.8M +52.04% | 155.8M -0.59% | |
Total Assets | 2.1B -13.31% | 2.4B -17.39% | 2.9B +1.25% | 2.9B -7.78% | |
Income Taxes Payable | N/A N/A | 0 -100.00% | 23.4M +2.80% | 22.7M -52.50% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 577.6M +5.83% | 545.8M -16.82% | 656.1M -23.52% | 857.9M -11.50% | |
Total Long-Term Debt | 767.1M -27.35% | 1.1B -19.07% | 1.3B +54.67% | 843.5M +0.14% | |
Total Long-Term Liabilities | 107.3M -0.11% | 107.5M -1.40% | 109.0M -2.00% | 111.2M +14.66% | |
Total Liabilities | 1.5B -15.04% | 1.7B -18.35% | 2.1B +13.47% | 1.8B -6.35% | |
Retained Earnings | 1.2B -7.34% | 1.3B -10.12% | 1.5B +16.98% | 1.2B +55.72% | |
Total Stockholders Equity | 642.1M -9.13% | 706.6M -14.99% | 831.3M -20.35% | 1.0B -10.19% | |
Total Shares Outstanding | 38.4M +0.95% | 38.1M +0.71% | 37.8M -9.72% | 41.9M -11.39% | |
Cash Flow | |||||
Cash from Operating Activities | 269.5M -15.90% | 320.4M -13.90% | 372.2M -43.07% | 653.7M +114.09% | |
Capital Expenditures | 35.6M -55.95% | 80.9M -21.99% | 103.7M +36.73% | 75.8M +41.55% | |
Cash from Investing Activities | 4.3M +105.38% | -79.9M -80.62% | -412.5M +141.63% | -170.7M +58.94% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -295.9M +14.05% | -259.4M -2,518.19% | 10.7M +101.81% | -591.9M +1,596.13% | |
Financials Ratio | |||||
Gross Margin | 28.35% -7.99% | 30.81% -6.56% | 32.98% +0.72% | 32.74% -0.39% | |
Operating Margin | -2.03% -40.96% | -3.44% -138.53% | 8.93% -27.63% | 12.34% +2.87% | |
Return on Assets | -4.24% -22.90% | -5.50% -175.94% | 7.25% -50.86% | 14.75% +23.58% | |
Return on Equity | -14.19% -25.76% | -19.11% -185.05% | 22.47% -44.18% | 40.26% +21.86% | |
Revenue Growth | -8.49% -60.06% | -21.26% -23.35% | -27.73% -187.76% | 31.60% -52.44% | |
Current Ratio | 0.94 -13.38% | 1.09 -15.03% | 1.28 +0.64% | 1.27 -8.41% | |
Cash Ratio | 0.06 +201.54% | 0.02 -61.16% | 0.05 -33.24% | 0.08 -59.70% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow